A Sarah Walker Selected Research

Anti-Bacterial Agents (Antibiotics)

4/2024	No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia.
4/2024	Prediction of pyrazinamide resistance in Mycobacterium tuberculosis using structure-based machine-learning approaches.
2/2024	Epidemiology and microbiology of recurrent UTI in women in the community in Oxfordshire, UK.
12/2023	Development and validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) score.
6/2023	Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).
1/2023	Microbial diversity and antimicrobial resistance in faecal samples from acute medical patients assessed through metagenomic sequencing.
1/2022	A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates.
1/2022	Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
1/2021	Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial.
1/2021	Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: A choice experiment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Sarah Walker Research Topics

Disease

56	Infections 02/2024 - 03/2003
17	Tuberculosis (Tuberculoses) 04/2024 - 07/2012
11	Acquired Immunodeficiency Syndrome (AIDS) 12/2019 - 08/2002
10	Bacterial Infections (Bacterial Infection) 01/2021 - 08/2006
10	HIV Infections (HIV Infection) 01/2019 - 03/2003
8	COVID-19 02/2024 - 01/2021
7	Clostridium Infections 01/2023 - 01/2012
6	Malaria 01/2022 - 01/2014
6	Inflammation (Inflammations) 01/2021 - 01/2012
5	Reinfection 02/2024 - 05/2014
5	Sepsis (Septicemia) 06/2023 - 04/2015
5	Anemia 01/2019 - 04/2011
4	Human Influenza (Influenza) 01/2021 - 01/2018
4	Disease Progression 01/2021 - 09/2004
4	Malnutrition (Nutritional Deficiencies) 01/2019 - 08/2006
3	Pneumonia (Pneumonitis) 04/2024 - 01/2007
3	Urinary Tract Infections (Urinary Tract Infection) 02/2024 - 10/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 08/2006
3	Body Weight (Weight, Body) 01/2019 - 09/2012
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2016 - 04/2013
2	Cellulitis 12/2023 - 10/2020
2	Neonatal Sepsis 06/2023 - 01/2020
2	Post-Acute COVID-19 Syndrome 09/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2005
2	Coinfection 01/2021 - 08/2004
2	Hepatitis C 05/2020 - 10/2018
2	Weight Gain 01/2020 - 01/2018
2	Frailty 01/2020 - 02/2004
2	Communicable Diseases (Infectious Diseases) 12/2019 - 01/2016
2	Cross Infection (Nosocomial Infection) 01/2019 - 04/2017
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2015 - 09/2015
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 03/2015 - 01/2014
2	Pneumococcal Infections 10/2014 - 01/2011
1	Liver Diseases (Liver Disease) 12/2023
1	Venous Insufficiency 12/2023
1	Clinical Deterioration 06/2023
1	Breakthrough Infections 01/2023
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022
1	Splenomegaly 01/2022
1	Fever (Fevers) 01/2021

Drug/Important Bio-Agent (IBA)

35	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2007
13	VaccinesIBA 01/2023 - 01/2011
13	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019 - 01/2007
7	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
6	BNT162 VaccineIBA 01/2022 - 01/2021
6	PENTAIBA 12/2019 - 08/2002
5	COVID-19 VaccinesIBA 01/2023 - 01/2021
4	Carbapenems (Carbapenem Antibiotics)IBA 06/2023 - 05/2017
4	Vancomycin FDA LinkGeneric 01/2022 - 08/2012
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 08/2006
4	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 01/2005
4	Zidovudine (Retrovir)FDA LinkGeneric 02/2016 - 09/2002
4	Nevirapine (Viramune)FDA Link 09/2012 - 01/2007
3	FluoroquinolonesIBA 06/2023 - 04/2017
3	Colistin (Coly-Mycin)FDA Link 06/2023 - 10/2018
3	AntibodiesIBA 01/2022 - 10/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
3	C-Reactive ProteinIBA 01/2021 - 01/2019
3	FidaxomicinIBA 11/2020 - 08/2012
3	Rifampin (Rifampicin)FDA LinkGeneric 10/2018 - 12/2012
3	Methicillin (Metin)FDA Link 10/2018 - 12/2012
3	abacavir (Ziagen)FDA Link 02/2016 - 09/2002
3	RNA (Ribonucleic Acid)IBA 01/2016 - 05/2004
2	Amoxicillin (Wymox)FDA LinkGeneric 04/2024 - 10/2018
2	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 04/2024 - 10/2018
2	AlbuminsIBA 12/2023 - 08/2012
2	Urea (Carbamide)FDA LinkGeneric 12/2023 - 01/2012
2	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2022 - 05/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 01/2018
2	Lipopolysaccharide ReceptorsIBA 01/2021 - 01/2019
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2019 - 04/2017
2	Raltegravir Potassium FDA Link 01/2018 - 07/2014
2	CreatinineIBA 02/2016 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 10/2015 - 09/2015
2	Conjugate VaccinesIBA 10/2014 - 01/2011
2	Lamivudine (Epivir)FDA Link 06/2006 - 09/2002
1	Pyrazinamide FDA LinkGeneric 04/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 02/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 02/2024
1	Pregnenolone Carbonitrile (PCN)IBA 09/2023
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 06/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 06/2023
1	beta-Lactamases (beta-Lactamase)IBA 06/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	hemoglobin AAIBA 01/2022
1	Histidine (L-Histidine)FDA Link 01/2022
1	Palivizumab FDA Link 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Oseltamivir (Tamiflu)FDA Link 01/2021
1	InterferonsIBA 01/2021

Therapy/Procedure

23	Therapeutics 01/2022 - 08/2002
12	Art Therapy 01/2021 - 05/2006
8	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 03/2003
6	Duration of Therapy 12/2020 - 04/2015
4	Antibiotic Prophylaxis 01/2020 - 05/2007
2	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2022
2	Contraindications 10/2018 - 12/2012